Literature DB >> 20177557

The battle against influenza: The role of neuraminidase inhibitors in children.

U Allen1.   

Abstract

Entities:  

Year:  2000        PMID： 20177557      PMCID： PMC2819961     

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  14 in total

1.  Influenza and hospitalizations in children.

Authors:  W P Glezen
Journal:  N Engl J Med       Date:  2000-06-08       Impact factor: 91.245

Review 2.  Zanamivir.

Authors:  S L Waghorn; K L Goa
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

3.  Influenza and the rates of hospitalization for respiratory disease among infants and young children.

Authors:  H S Izurieta; W W Thompson; P Kramarz; D K Shay; R L Davis; F DeStefano; S Black; H Shinefield; K Fukuda
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

4.  The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

Authors:  K M Neuzil; B G Mellen; P F Wright; E F Mitchel; M R Griffin
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

5.  Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

Authors:  F G Hayden; A D Osterhaus; J J Treanor; D M Fleming; F Y Aoki; K G Nicholson; A M Bohnen; H M Hirst; O Keene; K Wightman
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

6.  Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.

Authors:  A S Monto; D M Fleming; D Henry; R de Groot; M Makela; T Klein; M Elliott; O N Keene; C Y Man
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

7.  Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.

Authors:  A S Monto; D P Robinson; M L Herlocher; J M Hinson; M J Elliott; A Crisp
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

8.  Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.

Authors:  J A Hedrick; A Barzilai; U Behre; F W Henderson; J Hammond; L Reilly; O Keene
Journal:  Pediatr Infect Dis J       Date:  2000-05       Impact factor: 2.129

9.  Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.

Authors:  J J Treanor; F G Hayden; P S Vrooman; R Barbarash; R Bettis; D Riff; S Singh; N Kinnersley; P Ward; R G Mills
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

Review 10.  Influenza virus neuraminidase inhibitors.

Authors:  L V Gubareva; L Kaiser; F G Hayden
Journal:  Lancet       Date:  2000-03-04       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.